News
Piper Sandler analysts highlighted their top picks for biotechnology for investors amid the rollercoaster seen in the equity ...
Morgan Stanley lowered the firm’s price target on Alnylam (ALNY) to $268 from $284 and keeps an Equal Weight rating on the shares. The firm is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback